Novartis ends study of drug in high risk patients
ZURICH, Dec 20 – Swiss drugmaker Novartis said it was ending a study of a drug to treat high blood pressure after an independent body said it could increase risk to patients with a high risk of heart or kidney problems.
Novartis ends study of drug in high risk patients
December 20, 2011 By